Grund Nicholas

Track

Insider profile

Grund Nicholas's trades of Akebia Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
1.39
Quantity 84,829
Value US$118,294
Transaction date
Proposed sale
Price
2.10
Quantity 55,621
Value US$117,060
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-02
PlS Planned sale
87,211 +5.0%
152.24
US$3,361,712 		87,211 +5.0% 152.24 US$3,361,712
2026-02-04 2026-02-02
PlS Planned sale
6,444 -49.7%
330.72
US$246,123 		6,444 -49.7% 330.72 US$246,123
2026-02-04 2026-02-02
PlS Planned sale
14,119 +12.1%
333.36
US$4,872,860 		14,119 +12.1% 333.36 US$4,872,860
2026-02-02 2026-02-02
PrS Proposed sale
84,829
1.39
US$118,294 		84,829 1.39 US$118,294
2025-02-04 2025-02-03
PlS Planned sale
55,621 -11.2%
2.10
US$116,804 		55,621 -11.2% 2.10 US$116,804
2025-02-03 2025-02-03
PrS Proposed sale
55,621
2.10
US$117,060 		55,621 2.10 US$117,060